AstraZeneca (AZN) Beats on Q3 Earnings; Sales Slow Down
AstraZeneca PLC AZN reported third-quarter 2016 core earnings of $1.32 per American Depositary Share, comfortably beating the Zacks Consensus Estimate of 48 cents. Core earnings rose 12% year over year at constant currency rates (CER). Core earnings increased on the back of cost savings and a non-recurring tax benefit of 36 cents per share resulting from agreements on transfer pricing arrangements between various tax authorities […]